Contents
Download PDF
pdf Download XML
415 Views
108 Downloads
Share this article
Research Article | Volume 13 Issue:2 (, 2023) | Pages 1339 - 1342
Eyelid reconstruction, our experience at a tertiary care hospital
Under a Creative Commons license
Open Access
DOI : 10.5083/ejcm
Published
June 12, 2023
Abstract

Purpose: To report our experience on lid reconstruction in patients. Methods: This study was carried out in the Plastic Surgery Department of GMC Srinagar between from January 2009 to December 2019. It involved 25 patients, in whom lid reconstruction was done. Results: The records of all patients who underwent eyelid reconstructions were analysed for etiology, site and type of defect, method of reconstruction utilized, post operative complications and the final functional and cosmetic outcome. The study involved 25 patients (20 females and 5 males). Mean age was 57.5 years (range 12- 86 years). Most common etiology of lid defect was post tumor excision All 21 flaps used for partial reconstruction remained viable, whereas 1 of the 10 cheek flaps developed partial distal necrosis. Conclusions: Local flaps are the gold standard for lid reconstruction. KEY WORDS: Lower lid reconstruction, Local flaps, Chondromucosal graft

Keywords
Recommended Articles
Research Article
Use of Transverse Diameter of Femoral Vein in Predicting Postspinal Hypotension During Cesarean Section – A Prospective Observational Study
...
Published: 27/03/2025
Download PDF
Research Article
A Study of Obstetric Emergencies and Its Fetomaternal Outcome at Tertiary Care Centre
...
Published: 09/07/2025
Download PDF
Research Article
Assessment of Hemodynamic Response to Bolus Phenylephrine and Mephentermine in Hypotensive Parturients Undergoing Caesarean Delivery
Published: 30/06/2025
Download PDF
Research Article
A Prospective Study on the Pharmacotherapy of Bronchial Asthma in Paediatric Patients and Emphasis on Adverse Drug Reactions at a Tertiary Care Hospital
...
Published: 30/01/2025
Download PDF
Chat on WhatsApp
Copyright © EJCM Publisher. All Rights Reserved.